Maternal Marijuana Use and Fetal and Infant Outcome

Withdrawn before enrolling

Conditions studied: Cannabis Use Disorder, Pregnancy Related

In brief

Marijuana and cannabis-containing products are growing in popularity and availability in the United States, and use during pregnancy has increased dramatically. The overarching aim of this proposal is to provide pilot data for a submission which will explore the impact of chronic maternal marijuana use (primary or secondary) on fetal functioning, maternal reflective functioning and infant birth and neurodevelopmental outcomes. Chronically marijuana using pregnant women in treatment at the Center for Addiction and Pregnancy will be enrolled and asked to provide information about participants' marijuana and other licit and illicit substance use and feelings about parenting and participants' infant and undergo fetal monitoring at 36 weeks gestation. The neonates will undergo neurobehavioral examination during the first and fourth weeks of life.

Key facts

Study ID
NCT04266314
Run by
Johns Hopkins University
People needed
0
Starts
2019-04-10
Expected to finish
2021-02-15
Last updated by the study team
2021-02-17

Who can join

Age: 18 and older, up to 44. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.